**Comparing Treatment Approaches for Knee Ligament Laxity and Torn Ligaments: Interventional Orthobiologics Versus Surgical Options – A Regenexx Perspective** Knee...

**Gene Therapy Trial Evaluates Efficacy of Cancer-Targeting Virus in Treating Brain Tumors** In the ever-evolving landscape of cancer treatment, gene...

### 2024 PRP Randomized Controlled Trial Infographic 2.0 by Regenexx: A Comprehensive Overview In the ever-evolving field of regenerative medicine,...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: Histological and Biochemical...

**Comparative Analysis of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and Biochemical Study –...

**Comparative Study on the Effectiveness of Stem Cells and Microvesicles in Treating Chronic Renal Injury in Rats: A Histological and...

**Jonathan Thomas Appointed as New President and CEO of CIRM** In a significant development for the field of regenerative medicine,...

# $53 Million Allocated for Clinical and Translational Research Funding: A Leap Forward in Medical Innovation In a significant move...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Implications for Cell Death and Disease** The human...

**The Role of FOXM1-Dependent Histone Linker H1B in Human Epidermal Stem Cells: Insights from Cell Death & Disease** Human epidermal...

**Correction Notice: Influence of Thyroid Hormone Receptor β on Cancer Stem Cell Activity – Oncogene** In the ever-evolving field of...

**Nevada Approves Controversial Unproven Therapies, Joining Other States in Challenging FDA Regulations on Biologics** In a move that has sparked...

**QC Kinetix Shifts Focus from Upselling to Cost Reduction – Regenexx Reports** In the ever-evolving landscape of regenerative medicine, QC...

# Effective Approaches for Modeling Aging and Age-Related Diseases Aging is an inevitable biological process that affects all living organisms....

**Infographic on the 2024 PRP Randomized Controlled Trial by Regenexx: A Comprehensive Overview** In the ever-evolving field of regenerative medicine,...

# Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Advancement – Insights from Signal Transduction and Targeted Therapy...

**Semaphorin 3C (Sema3C) Modulates Stromal Microenvironment to Facilitate Hepatocellular Carcinoma Progression – Insights from Signal Transduction and Targeted Therapy** Hepatocellular...

**Lung Institute Stem Cell Clinic Ordered to Pay $9 Million in Class Action Lawsuit Settlement** In a landmark decision, the...

# Improvement of Endothelial Function and Reduction of Portal Vein Injury with miRNA-25-3p-Expressing Mesenchymal Stem Cells – Scientific Reports ##...

**Innovative Stem Cell Therapy for Treating Cystic Fibrosis-Related Sinusitis** Cystic fibrosis (CF) is a genetic disorder that primarily affects the...

**Innovative Stem Cell Therapy for Treating Sinusitis in Cystic Fibrosis Patients** Cystic fibrosis (CF) is a genetic disorder that primarily...

**Cytosolic N-terminal Formyl-Methionine Deformylation Promotes Cancer Stem Cell Characteristics and Tumor Progression** Cancer remains one of the most formidable challenges...

**Deformylation of Cytosolic N-terminal Formyl-Methionine Promotes Cancer Stem Cell Characteristics and Tumor Progression – Scientific Reports** Cancer remains one of...

**miR-124-3p Reduces EGR1 Expression to Mitigate Ischemia-Hypoxia Reperfusion Injury in Human iPS Cell-Derived Cardiomyocytes – Scientific Reports** Ischemia-hypoxia reperfusion injury...

**miR-124-3p Suppresses Ischemia-Hypoxia Reperfusion Injury in Human iPS Cell-Derived Cardiomyocytes by Downregulating EGR1 – Scientific Reports** Ischemia-hypoxia reperfusion (IHR) injury...

**Lack of Response from FDA Commissioner Robert Califf on Stem Cell Clinics Raises Concerns** In recent years, the burgeoning field...

# Uniting the Community: Highlights from the 2nd Annual ALSP Conference The 2nd Annual Alternative Legal Service Providers (ALSP) Conference,...

**Uniting the Community at the 2nd Annual ALSP Conference** In an era where legal innovation is rapidly transforming the landscape...

**Pioneering 3D Brain Models Incorporate Cells from Multiple Donors: A Leap Forward in Neuroscience** In the ever-evolving field of neuroscience,...

**First-of-Their-Kind 3D Brain Models Incorporate Cells from Multiple Donors: A Leap Forward in Neuroscience** In a groundbreaking advancement for neuroscience,...

Regenexx Stem Cell Institute of America Found Guilty in FTC Case

The Regenexx Stem Cell Institute of America, a prominent provider of stem cell therapy, has recently been found guilty in a case brought by the Federal Trade Commission (FTC). The case alleged that the institute had made false and misleading claims about the effectiveness of its stem cell treatments, deceiving consumers and violating federal law.

Stem cell therapy has gained popularity in recent years as a promising treatment for a variety of medical conditions, from joint pain to autoimmune diseases. However, the field is still relatively new and research is ongoing to determine the full extent of its benefits and risks.

The Regenexx Stem Cell Institute of America claimed that its treatments could cure or significantly improve a wide range of conditions, including arthritis, tendonitis, and even neurological disorders. The FTC found that these claims were not supported by scientific evidence and were therefore deceptive to consumers.

In a statement, the FTC emphasized the importance of ensuring that healthcare providers are truthful in their advertising and do not mislead patients about the potential benefits of treatments. The agency also warned consumers to be cautious when considering stem cell therapy, as there are many unproven and potentially dangerous treatments on the market.

The case against the Regenexx Stem Cell Institute of America serves as a reminder of the need for transparency and accountability in the healthcare industry. Patients should always do their own research and consult with qualified medical professionals before undergoing any treatment, especially one as cutting-edge as stem cell therapy.

Moving forward, it is crucial for regulators to continue monitoring the stem cell industry and holding providers accountable for making false or misleading claims. By promoting honesty and integrity in healthcare marketing, we can help ensure that patients receive safe and effective treatments that are based on sound scientific evidence.